🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ana Osório

Centre for Biomedical Network Research on Rare Diseases

ORCID: 0000-0001-8124-3984

Also affiliated with Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.8Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

British Journal of Cancer(2020)10.1038/s41416-020-0900-0
Top 10%
2.1DataRank
Top 10%68 citations

Dominique‐Laurent Couturier, Anna Paterson, Anthony N. Karnezis, Christine Chow, Tayyebeh M. Nazeran +92 more

Papers

Driven by 15 papers — median percentile 81. Top paper: “Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium”.

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

British Journal of Cancer(2020)10.1038/s41416-020-0900-0
Top 10%
2.1DataRank
Top 10%68 citations

Dominique‐Laurent Couturier, Anna Paterson, Anthony N. Karnezis, Christine Chow, Tayyebeh M. Nazeran +92 more

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0103
N/A
1.8DataRank · unranked
76 citations

Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S. Chiu +134 more

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

JAMA Oncology(2022)10.1001/jamaoncol.2021.6744
N/A
0.792DataRank · unranked
196 citations

Leila Dorling, Sara Carvalho, Jamie Allen, Anna González‐Neira, Renske Keeman +89 more

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa030
N/A
0.769DataRank · unranked
168 citations

Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber +56 more

Incorporating progesterone receptor expression into the PREDICT breast prognostic model

European Journal of Cancer(2022)10.1016/j.ejca.2022.06.011
N/A
0.757DataRank · unranked
25 citations

Renske Keeman, Fiona M. Blows, Roger L. Milne, Graham G. Giles, Anthony J. Swerdlow +95 more

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

The Journal of Pathology Clinical Research(2023)10.1002/cjp2.311
Top 27%
0.751DataRank
Top 27%28 citations

Eunyoung Kang, Ashley Weir, Peter Rambau, Cheng‐Han Lee, Gregg Nelson +95 more

Characterization of the Cancer Spectrum in Men With GermlineBRCA1andBRCA2Pathogenic Variants

JAMA Oncology(2020)10.1001/jamaoncol.2020.2134
N/A
0.633DataRank · unranked
67 citations

Goska Leslie, Daniel R. Barnes, and the CIMBA Group, Bjarni A. Agnarsson, Kristiina Aittomäki +95 more

Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

British Journal of Cancer(2022)10.1038/s41416-022-02014-y
N/A
0.312DataRank · unranked
7 citations

Eunyoung Kang, Nicola S. Meagher, Gregg Nelson, Prafull Ghatage, Cheng‐Han Lee +88 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

Research Square(2025)10.21203/rs.3.rs-7572112/v1
N/A
0DataRank · unranked
0 citations

Tibor A. Zwimpfer, Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana +95 more

The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing

UNC Libraries(2020)10.17615/kvd4-4s97
N/A
0DataRank · unranked
8 citations

James M. Flanagan, Hoda Anton‐Culver, Ellen L. Goode, Wendy R. Brewster, Matthias Dürst +95 more

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

UNC Libraries(2020)10.17615/rh7v-bc86
N/A
0DataRank · unranked
2 citations

Fiona Lalloo, D. Stoppa-Lyonnet, N. Lindor, C. Casella, I. L. Andrulis +95 more

Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

Kölner Universitäts PublikationsServer (Universität zu Köln)(2020)10.17615/wt6m-3p20
N/A
0DataRank · unranked
0 citations

Jenny Lester, Xianshu Wang, Teresa Ramón y Cajal, Heli Nevanlinna, Daniel Cuadras +27 more

First international workshop of the ATM and cancer risk group (4-5 December 2019)

Familial Cancer(2021)10.1007/s10689-021-00248-y
N/A
0DataRank · unranked
19 citations

Douglas F. Easton, Anne‐Laure Renault, Sean V. Tavtigian, Jonine L. Bernstein, Zsofia Kote‐Jarai +51 more

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

British Journal of Cancer(2023)10.1038/s41416-023-02263-5
N/A
0DataRank · unranked
19 citations

Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John +87 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA -deficient tubo-ovarian high-grade serous carcinoma

medRxiv(2025)10.1101/2025.09.17.25335919
N/A
0DataRank · unranked
0 citations

Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana, Laura Twomey +95 more